Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

NCT00440011 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: bimatoprost 0.03% eye drops
DRUG: travoprost 0.004% eye drops

Sponsor

Allergan